Meeting
2011 ASCO Annual Meeting
A pediatric phase I trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: A Children's Oncology Group Phase I Consortium Study.
Authors
T. R. Hummel
Cincinnati Children's Hospital Medical Center, Cincinnati, OH
T. R. Hummel , L. M. Wagner , C. H. Ahern , R. M. McGovern , M. M. Ames , R. J. Gilbertson , T. M. Horton , A. M. Ingle , B. Weigel , S. Blaney
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Pediatric Oncology
Track
Pediatric Oncology
Sub Track
Pediatric Solid Tumors
Clinical Trial Registration Number
NCT01076530
Citation
J Clin Oncol 29: 2011 (suppl; abstr 9579)
Abstract #
9579
Poster Bd #
43D
Abstract Disclosures
Similar Posters
Poster
2014 ASCO Annual Meeting
A phase 1 study of the c-Met inhibitor tivantinib (ARQ 197, IND#112603) in children with relapsed or refractory solid tumors: A Children’s Oncology Group study.
First Author: James I. Geller
Poster
2013 ASCO Annual Meeting
A phase I trial and pharmacokinetic study of trebananib (AMG386) in children with recurrent or refractory solid tumors: A Children’s Oncology Group Phase 1 Consortium report.
First Author: Sarah Leary
Poster
2012 ASCO Annual Meeting
Phase I trial of temsirolimus (TEM), irinotecan (IRN), and temozolomide (TMZ) in children with refractory solid tumors: A Children's Oncology Group study.
First Author: Rochelle Bagatell
Poster
2012 ASCO Annual Meeting
Phase I trial of ixabepilone and vorinostat in metastatic breast cancer.
First Author: Thehang H. Luu